A love letter to Oxford!


A city abundant with history, science and beauty. And some weird type of magic that is hard to put into words. That was my first impression of Oxford in August when I first arrived, and now after finishing my HiLIFE Traineeship here, the feeling has not changed. Except that I now know that here history is not left in the past but it’s present every day when you study in a library built in the 14th century or participate in ceremonies that have stayed intact for centuries. Also, science and learning are not hidden in big buildings away from the city but are instead scattered all across the town, with colleges and departments found behind every street corner. Here, the university is everywhere.

Continue reading “A love letter to Oxford!”

Greetings from Basel, Switzerland


My name is Teemu Kuosmanen and I am here in Basel for my master’s thesis research which focuses on the exciting and relatively novel field of mathematical oncology.

Cancer is conventionally seen as a genetic disease and characterized by the accumulation of genetic and epigenetic alterations. While this is of course per se true, such definition naturally implies that the focus of cancer research should be in the systematic study of mutations and genes. Indeed, this has and continues to be the central dogma and interest of mainstream cancer research. Continue reading “Greetings from Basel, Switzerland”

Hej från Stockholm!

Hello! My name is Abigail Dove and I’m a master’s student in the University of Helsinki’s Neuroscience program. I recently arrived in Stockholm, where I am conducting my master’s thesis research at the Karolinska Institute’s Aging Research Center.  My project centers on something I view as one of the most interesting problems in public health: The increased risk of dementia conferred by type 2 diabetes. Specifically, I will be analyzing longitudinal Swedish population data to determine the extent to which a diagnosis of diabetes or prediabetes increases the risk of progressing from prodromal cognitive impairment to overt dementia, and whether improved glycemic control could stabilize or even reverse this trajectory.

Continue reading “Hej från Stockholm!”